ACAD
ACADIA Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $3.55B | Price | $22.37 |
| Volume | 1.82M | Change | -1.45% |
| P/E Ratio | 15.7 | Open | $22.50 |
| Revenue | $957.8M | Prev Close | $22.70 |
| Net Income | $226.5M | 52W Range | $13.40 - $26.65 |
| Div Yield | N/A | Target | $29.35 |
| Overall | 64 | Value | 75 |
| Quality | 57 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyACADIA Pharmaceuticals Inc. (ACAD) is a leading Healthcare company in the business industry, currently trading at $21.99 with a market capitalization of $3.55 billion. The stock is positioned in the upper portion of its trading range, demonstrating average quality indicators with a MarketXLS quality score of 57.
Today's trading session shows ACAD with a volume of 831K shares. The stock opened down 0.88% from yesterday's close of $22.70. Current analyst estimates project earnings of $0.53 per share for this year, with next year targeting $0.84.
ACAD demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including VNDA, BMY, PFE, JNJ, LLY.
Key investment considerations for ACAD include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 33.5%. The stock shows reasonable valuation levels based on valuation analysis.
Analysis generated on November 4, 2025 at 01:31 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACAD | $22.37 | -1.5% | 1.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW